0000950170-25-010533.txt : 20250129 0000950170-25-010533.hdr.sgml : 20250129 20250129163008 ACCESSION NUMBER: 0000950170-25-010533 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250128 FILED AS OF DATE: 20250129 DATE AS OF CHANGE: 20250129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REED VICKIE S CENTRAL INDEX KEY: 0001405637 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 25569747 BUSINESS ADDRESS: BUSINESS PHONE: 858-623-5665 MAIL ADDRESS: STREET 1: TORREYPINES THERAPEUTICS, INC. STREET 2: 11085 NORTH TORREY PINES RD, STE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 ownership.xml 4 X0508 4 2025-01-28 0001403708 Evoke Pharma Inc EVOK 0001405637 REED VICKIE S C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 true false false false false Stock Option (Right to Buy) 4.45 2025-01-28 4 A false 5833 0 A 2035-01-27 Common Stock 5833 5833 D The total number of shares of common stock subject to the option shall vest one-third of the total number of shares each one-year period after the vesting commencement date, so that the option shall be fully vested on the third anniversary of the vesting commencement date, subject to the Holder's continued service to the Company through each such vesting date. /s/ Matthew J. D'Onofrio, Attorney-in-fact for Vicke S. Reed 2025-01-29